ABP 206 (nivolumab biosimilar) - Amgen
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Nivocad (nivolumab biosimilar) - Biocad
cisplatin - Generic mfg.
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer (clinicaltrials.gov) - Sep 30, 2026 - P3 | N=636 | Active, not recruiting | Sponsor: National Cancer Institute (NCI) | Trial completion date: Jan 2027 ➔ Jan 2030 | Trial primary completion date: Jan 2027 ➔ Jan 2030 
IO biomarker • Trial completion date • Trial primary completion date • Tumor mutational burden • Head and Neck Cancer • Oncology • Oropharyngeal Cancer • Solid Tumor • Squamous Cell Carcinoma of Head and Neck • PD-L1
http://clinicaltrials.gov/ct2/show/NCT03811015
 
Sep 30, 2026
 
Prev Next